Sarepta stock has tanked. Most investors don’t see the drugmaker’s executive management as credible following the failure to disclose a patient death, a BMO survey suggests.

Rich's Ice Cream is recalling over 110,000 cases of ice cream bars in 23 states after potential listeria contamination. Here's what to know.

The crisis over Sarepta Therapeutics' Duchenne therapy offers a valuable lesson: Listening to critics, and responding with ...

CNBC's Tanaya Macheel joins 'The Exchange' to discuss what's behind The Ether Machine, crypto legislation and more.

H.C. Wainwright sets a rare $0 target for Sarepta Therapeutics amid FDA scrutiny over its Duchenne muscular dystrophy gene therapy Elevidys. Read more here.

U.S. Food & Drug Administration (FDA) warning letter to a prominent wellness product and services company offers a blunt reminder that medical device requirements cannot be waived or overlooked merely ...

Learn practical strategies to boost your confidence and own your style, even with a receding hairline. Embrace self-assurance every day with these tips.

The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...

The FDA has named Dr. George Tidmarsh to lead its drug division, putting him at the helm of the agency’s drug approval process.

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...

The agency also revoked Sarepta's platform technology designation for AAVrh74 Friday and issued a safety communication saying ...

A standoff over Elevidys could have major consequences for Duchenne patients, gene therapy companies and the perception of ...